Ayman Saad
@aymansaadOSUBMT/Cell Therapy. KFSHRC (Riyadh, Saudi Arabia). Ex-Professor, Ohio State University
Similar User
@MartinTallman
@MKD_BMT
@syed_abutalibmd
@beatalleukemia
@MediHumdani
@TaniaJain11
@DrBattiwalla
@DrMarcosdelima
@AndreWi54721839
@BipinSavani
@DQBMD
@DrCCutler
@TalhaBadarMD
@hemant_murthy
@HenrychihangFu1
Revolutionary! 👌
FDA approves revumenib for relapsed or refractory acute leukemia with a KMT2A translocation. fda.gov/drugs/resource… #OCENewsBurst
#Weekend_review on #menin_inhibitors for treatment of leukemia in light on Revumenib approval (AUGMENT-101) #leusm #AML 🧵 FDA approves revumenib for relapsed or refractory acute leukemia with a KMT2A translocation fda.gov/drugs/resource…
I’m happy to have led the FELIX registrational study @SylvesterCancer that resulted in the FDA approval of obecabtagene autoleucel today for R/R B Cell ALL.
Just an FYI that the #ASH24 @ASH_hematology annual meeting app is out and has been populated with all the abstracts: apps.apple.com/us/app/ash-202… As meeting apps go this one is really very good.
A good piece of information on CNS orevention prior to alloSct Prophylactic Cranial Irradiation prior to HCT for Acute Lymphoblastic Leukemia: To Boost or Not To Boost. pubmed.ncbi.nlm.nih.gov/39417015/
Nice to see siltuximab curbing ICANS (unlike Toci). And that makes perfect sense! Great work Amneet Bajwa 👌@tvoorheesmd @jmaakaron
Excited to share our multi-center experience utilizing siltuximab for CRS and ICANS! With caveats of retrospective data, siltuximab appeared to be effective in the majority of patient with CRS and/or ICANS, including patients with prior Toci exposure. doi.org/10.1182/blooda…
Congratulations Dr. Aljurf for lifetime achievement award @aljurf100
هيئة البحث والتطوير والابتكار تكرم اثنين من خبراء #التخصصي تقديراً لمساهماتهم البارزة في مجال الأبحاث الصحية، وذلك ضمن حفل افتتاح #ملتقى_الصحة_العالمي توج البروفيسور فراس خليل، رئيس قسم جراحة القلب، بجائزة التميز في الأبحاث الصحية والابتكار التطبيقي. كما كُرم البروفيسور محمود…
@RabiHannaMD @ClevelandClinic on gene therapy for hemoglobin apathy at @SocietyofHemOnc Saudi Arabia @KFSHRC
Great talks on evolution of CCUS to AML & Prognostic significance of Molecular profile of AML by @AkEisfeld @OSUCCC_James @OSUWexMed at @SocietyofHemOnc Saudi Arabia @KFSHRC
@UrbanoIspizuaMD great talks (academic CAR T and CAR T platforms) in @SocietyofHemOnc Saudi Arabia @KFSHRC
With increasing pola using in frontline, is CD19 bridge to CD19 CAR possible? We think so, with CD19 directed ADC loncastuximab in @CIBMTR database #lymsm onlinelibrary.wiley.com/doi/10.1002/jh…
I am pleased to discuss how our research is advancing CAR-T cell therapy, increasing its effectiveness while reducing side effects. The future of cancer treatment is indeed promising. #InnovationStartsAtMayo
اللهم لك الحمد و الشكر و لك الثناء الحسن 🙏🏼❤️ Delighted to share our latest publication on aGVHD following Lung Transplant @AhmedAlNughmush @Haemophage journals.lww.com/transplantjour…
Well, @MassGenBrigham / @harvardmed and @UMass media relations are about to have a very busy day. MicroRNA this year. Congratulations to Gary Ruvkun and Victor Ambros. newscientist.com/article/245080…
Important paper published in @BloodJournal describing 41 patients with #TTP who were managed with Caplacizumab alone without therapeutic plasma exchange. Are we seeing the start of a change of how immune TTP patients will be managed in future? Paper behind pay wall.…
📣Join us for the upcoming @TheIACH Post IMS 2024 roundtable 🗓️Monday, October 7 2024 ⏲️ 7PM CET | 1PM NY Register for FREE ⬇️⬇️ bit.ly/4dAAR7I @szusmani @End_myeloma @PerrotAurore @ThierryFacon @NBahlis @mbeksac56 @Mohty_EBMT
Save the Date! @calliecoombsmd @JohnPLeonardMD @Ramikomrokji @farrukhawan @NicholasShortMD @szusmani @DrKrinaPatel @corinneShahmehdi @jmaakaron @CLachowiez Register at louisville.edu/medicine/cme/e… @UofLBCC @UofLHealth @UofLMedicine @uoflmedschool @uofl
#WBMT webinar, hope to see you there... #PTCy #PTCyRules us02web.zoom.us/webinar/regist…
Congratulations Dr. @hindahmed161 - this is really amazing! 👌
Today we at hematology oncology department Riyadh, Saudi Arabia celebrated the opening of the first histiocytic clinic in the region I feel so proud @ECDGA @NGHAnews @SSBMT @HistiocyteSoc
United States Trends
- 1. #UFC309 271 B posts
- 2. Jon Jones 134 B posts
- 3. Jon Jones 134 B posts
- 4. Jon Jones 134 B posts
- 5. Chandler 84 B posts
- 6. Oliveira 69,6 B posts
- 7. Kansas 21,1 B posts
- 8. #discorddown 6.499 posts
- 9. Bo Nickal 8.538 posts
- 10. Do Bronx 10,5 B posts
- 11. #MissUniverse 423 B posts
- 12. Tennessee 54,8 B posts
- 13. Rock Chalk 1.212 posts
- 14. Tatum 27,4 B posts
- 15. #BYUFootball 1.289 posts
- 16. Keith Peterson 1.288 posts
- 17. #kufball 1.019 posts
- 18. Oregon 34,1 B posts
- 19. Paul Craig 4.402 posts
- 20. Beck 21,6 B posts
Who to follow
-
Martin S. Tallman, MD
@MartinTallman -
Mohamed Kharfan-Dabaja, MD, MBA
@MKD_BMT -
Syed Ali Abutalib
@syed_abutalibmd -
Dr. Uma Borate: Associate Professor
@beatalleukemia -
Mehdi Hamadani, MD
@MediHumdani -
Tania Jain
@TaniaJain11 -
Dr. Minoo Battiwalla
@DrBattiwalla -
Marcos de Lima
@DrMarcosdelima -
Andre Williams
@AndreWi54721839 -
Bipin Savani
@BipinSavani -
Qaiser Bashir
@DQBMD -
Corey Cutler
@DrCCutler -
Talha Badar
@TalhaBadarMD -
Hemant S. Murthy MD
@hemant_murthy -
MyelomaLymphoma
@HenrychihangFu1
Something went wrong.
Something went wrong.